Mounjaro®
Starting from £179.99/mo
Start journey Learn moreThere is no standard payment plan for Mounjaro available through private UK pharmacies or clinics. Mounjaro is a prescription-only medicine, and the cost is charged per pen at the point of supply — not spread across monthly instalments the way a phone contract might be. That said, understanding exactly how private Mounjaro pricing is structured can make the outgoings much more predictable. This page explains the facts, the common misunderstandings, and what questions are genuinely worth asking any provider before you start.
At your door the next working day.
Free, tracked, plain packaging.
BMI isn't the whole story, but it's where clinicians start. Check yours in ten seconds — nothing is stored, nothing is shared.
Ten seconds. Private — nothing is stored or shared.
Your result updates live in the card alongside.
Your result
Your BMI is
—
which is in the healthy weight range
Start journeyBMI doesn't determine eligibility — only a clinician can assess whether treatment is right for you.
The problem
The nume way
clinician review. Free next working day delivery.
How it works
Tell us about your health, history and goals. Free, online, and confidential — no commitment, no waiting room.
Our team reviews your health the same day — never an algorithm, and approves your treatment there and then if eligible.
Order by 12pm, dispatched same day, delivered free the next working day — the nume Promise.
The most common question our prescribers hear most weeks is some version of: "Can I pay for Mounjaro monthly, like a direct debit?" It's a completely reasonable thing to ask. The answer, for almost every regulated UK pharmacy, is no, not in the sense of a formal credit or finance agreement built into the service itself.
Mounjaro is a prescription-only medicine. Regulated pharmacies dispense it only after a clinician has reviewed your case and issued a prescription. That review happens before each supply, which means costs occur per order, not on an ongoing subscription. Some providers dress up a repeat-prescription cycle as a "monthly plan", but what they mean is: you pay each time your prescription is re-issued, usually every four weeks. That's a useful rhythm, but it is not a payment plan in the financial sense.
A small number of third-party buy-now-pay-later or healthcare credit services can technically be used at checkout on some platforms. If you go that route, read the interest terms carefully. A deferred payment on a prescription medicine does not reduce the underlying cost; it adds to it.
Mounjaro's list price rose substantially in the UK from 1 September 2025. Eli Lilly's price increases pushed the highest-dose pen's list price from around £122 to around £330. As reported widely at the time, private-market prices for Mounjaro now typically sit somewhere between £149 and £375 per month, depending on the dose and the provider.
Dose matters a lot here. Treatment starts at 2.5 mg (the body's settling-in period) and titrates upward over several months. The 2.5 mg and 5 mg pens carry lower costs than the 10 mg or 15 mg pens. A patient who reaches the maintenance dose will pay more per pen than they did at the start, which surprises people who saw a lower price quoted for the starter dose and assumed that figure held throughout.
What any quoted price includes also varies sharply between providers. Some headline figures exclude the consultation, the prescription fee, and delivery. For a full picture of the UK private market, the Mounjaro price comparison for UK patients covers what different providers typically bundle in and what tends to be charged separately. At nume, one transparent price covers consultation, prescription, next-working-day tracked delivery and 7-day aftercare, no separate line items.
For some people, the question of payment plans is made irrelevant by NHS eligibility. NICE recommended tirzepatide (Mounjaro) for NHS use in December 2024, NICE technology appraisal TA1026 sets out the criteria in full. NHS access is phased: from around June 2025, adults with a BMI of 40 or above plus four or more of five specified weight-related conditions became eligible for the first cohort. A second cohort (BMI 35–39.9 with four or more conditions) was activated in June 2026.
If you don't meet those criteria yet, or your GP practice isn't participating in the new prescribing contract, a private prescription through a regulated pharmacy is currently the only practical route. The clinical requirements for Mounjaro page covers both NHS and private eligibility in more detail. The NHS route is free at point of use but involves waiting lists and strict criteria; private treatment has an upfront cost but no waiting list and no referral required.
Worth checking: the NHS BMI eligibility thresholds are 2.5 kg/m² lower for South Asian, Chinese, Middle Eastern, Black African and African-Caribbean backgrounds, so some people are eligible at a BMI below 40 or 35 under the phased rollout.
If you're paying privately, the clearest way to budget is to look at the full course over the likely treatment period rather than just the starter-pen cost. Most people titrate over three to six months before reaching a maintenance dose. During that time, the pen price increases at each step. The NHS tirzepatide information page explains how the medicine works and what a typical treatment course looks like at a clinical level, which helps set realistic expectations about duration.
Practical steps worth taking before you start: ask any provider to confirm the full-dose price as well as the starter price; confirm what's included (prescription, delivery, clinical review, aftercare); check the pharmacy's registration on the GPhC register, a registered pharmacy will show its premises registration number. At nume, ours is 9012878, verifiable directly on the register.
Eating well alongside treatment genuinely matters for outcomes, and it doesn't have to cost more. Our meal plans for Mounjaro are designed around how the medicine affects appetite and digestion, which can help with both tolerability and results during the titration phase. The food guidance for Mounjaro page covers the practical nutritional detail, protein, hydration, managing reduced appetite sensibly.
If the cost of Mounjaro at the dose you need is the limiting factor, it's also worth discussing whether treatment is the right fit at this point. Patients who are weighing up their options can also read about what a replacement for Mounjaro might look like, including alternative medicines and approaches that may suit different circumstances or budgets. Speak to our prescribers at nume for a clear-eyed view of what private treatment would involve for your situation, with no obligation.
The people
Superintendent Pharmacist (GPhC No. 2217101)
Accountable for the safe running of our registered pharmacy, from every dispensing check to every dispatch.
Clinical Lead (GPhC No. 2231744)
Sets our clinical standards and checks everything we publish against current MHRA guidance.
Independent Prescriber (GPhC No. 2084501)
Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.
Independent Prescriber (GPhC No. 2083426)
Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.